MY193448A - Anti-cd166 antibodies, and activatable anti-cd166 antibodies, and methods of use thereof - Google Patents

Anti-cd166 antibodies, and activatable anti-cd166 antibodies, and methods of use thereof

Info

Publication number
MY193448A
MY193448A MYPI2017001623A MYPI2017001623A MY193448A MY 193448 A MY193448 A MY 193448A MY PI2017001623 A MYPI2017001623 A MY PI2017001623A MY PI2017001623 A MYPI2017001623 A MY PI2017001623A MY 193448 A MY193448 A MY 193448A
Authority
MY
Malaysia
Prior art keywords
antibodies
methods
activatable
bind
activatable anti
Prior art date
Application number
MYPI2017001623A
Inventor
Luc Roland Desnoyers
Jason Gary Sagert
Jonathan Terrett
James William West
Shweta Singh
Annie Yang Weaver
Original Assignee
Cytomx Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytomx Therapeutics Inc filed Critical Cytomx Therapeutics Inc
Priority claimed from PCT/US2016/030785 external-priority patent/WO2016179285A1/en
Publication of MY193448A publication Critical patent/MY193448A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention relates generally to antibodies that bind CD166, activatable antibodies that specifically bind to CD166 and methods of making and using these anti-CD166 antibodies and anti-CD166 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications. (Fig.1)
MYPI2017001623A 2015-05-04 2016-05-04 Anti-cd166 antibodies, and activatable anti-cd166 antibodies, and methods of use thereof MY193448A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562156835P 2015-05-04 2015-05-04
PCT/US2016/030785 WO2016179285A1 (en) 2015-05-04 2016-05-04 Anti-cd166 antibodies, activatable anti-cd166 antibodies, and methods of use thereof

Publications (1)

Publication Number Publication Date
MY193448A true MY193448A (en) 2022-10-13

Family

ID=87569342

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2017001623A MY193448A (en) 2015-05-04 2016-05-04 Anti-cd166 antibodies, and activatable anti-cd166 antibodies, and methods of use thereof

Country Status (1)

Country Link
MY (1) MY193448A (en)

Similar Documents

Publication Publication Date Title
MX2021014735A (en) Anti-cd166 antibodies, activatable anti-cd166 antibodies, and methods of use thereof.
ZA201707645B (en) Anti-cd71 antibodies, activatable anti-cd71 antibodies, and methods of use thereof
NZ759442A (en) Activatable anti-pdl1 antibodies, and methods of use thereof
MX2021013467A (en) Anti-pdl1 antibodies, activatable anti-pdl1 antibodies, and methods of use thereof.
ZA202107931B (en) Anti-tau antibodies and methods of use
WO2016014974A3 (en) Anti-cd3 antibodies, activatable anti-cd3 antibodies, multispecific anti-cd3 antibodies, multispecific activatable anti-cd3 antibodies, and methods of using the same
MX2020009649A (en) Monoclonal antibodies against bcma.
PH12018500711A1 (en) Anti-pd1 antibodies and methods of use
MX2020002198A (en) Activatable anti-cd166 antibodies and methods of use thereof.
PH12017500861A1 (en) Anti-interleukin-33 antibodies and uses thereof
PH12017502180A1 (en) Tau-binding antibodies
PH12016501644B1 (en) Binding proteins and methods of use thereof
SG10201804931QA (en) Anti-cll-1 antibodies and immunoconjugates
MX2017008819A (en) Anti-cd47 antibodies and uses thereof.
SG10201808259TA (en) Anti-jagged1 antibodies and methods of use
PH12017502207A1 (en) Tau-binding antibodies
MX2016004853A (en) ANTI-Ly6E ANTIBODIES AND METHODS OF USE.
SG10201907901XA (en) Antibodies, uses & methods
MY193448A (en) Anti-cd166 antibodies, and activatable anti-cd166 antibodies, and methods of use thereof